Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874716-14-000007
Filing Date
2014-04-25
Accepted
2014-04-25 16:04:07
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idxx-20140331x10q.htm 10-Q 2108813
2 EX-31.1 idxx-20140331ex311c1b3e1.htm EX-31.1 21497
3 EX-31.2 idxx-20140331ex31257d2c8.htm EX-31.2 21305
4 EX-32.1 idxx-20140331ex3211e2fb3.htm EX-32.1 10149
5 EX-32.2 idxx-20140331ex322265051.htm EX-32.2 10415
  Complete submission text file 0000874716-14-000007.txt   9088869

Data Files

Seq Description Document Type Size
6 EX-101.INS idxx-20140331.xml EX-101.INS 1590284
7 EX-101.SCH idxx-20140331.xsd EX-101.SCH 34371
8 EX-101.CAL idxx-20140331_cal.xml EX-101.CAL 56975
9 EX-101.DEF idxx-20140331_def.xml EX-101.DEF 68197
10 EX-101.LAB idxx-20140331_lab.xml EX-101.LAB 255545
11 EX-101.PRE idxx-20140331_pre.xml EX-101.PRE 233384
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19271 | Film No.: 14785667
SIC: 2835 In Vitro & In Vivo Diagnostic Substances